New Delhi: Mukwiingula muzeezo wa Fresenius Medical Care, Specialty Expert Committee (SEC) ya Central Drugs Standard Control Organization (CDSCO) yakalumbaizya inkamu kuti ipe kaambo kakuzumizyigwa antoomwe a phase III clinical trial data ya calcium chloride dihydrate antoomwe a data ya post-marked survement kuzwa kuzisi zyakazumizigwa.
Inkampani yakabikka kale foomu yakupanga akusambala musamu wa calcium chloride dihydrate uujisi mweelwe wa 100 mmol/L, walo uubelesyegwa “kusilisya calcium mubusena bwakubelesya nsinga zyamuntu (CRRT), nzila yakugwisya bulowa butabeleki kabotu (buzuba abuzuba) (CLED) alimwi akusilikwa kwa plasma (TPE) antoomwe a citratic cipango. zyeelede kubantu bapati abana” mpawo wakaamba twaambo twakugwisigwa muchibaka chachitatu achachina chamasunko aakusilikwa.
Kkomiti yakabona kuti chintu eechi chakazumizigwa mumasi aakuYulopu mbuli Portugal, United Kingdom, Brazil, Switzerland, France antoomwe a Denmark.
Musamu wa calcium chloride dihydrate ngu CaCl2 2H2O, ooyo uuli calcium chloride uulaa ma molecule obile aameenda kuli yuniti yomwe ya calcium chloride. Nchintu chituba chilimbuli bbwe, chikonzya kunywika mumaanzi mpawo chikonzya kunyonyoona maanzi kuzwa mumuwo.
Calcium chloride dihydrate nchintu chikonzya kubelesegwa mbuli nzila yakunyonyoona chitin kuti yanyonyooka mu methanol. Chibeleka mulimo mupati mukutyola bupange bwa chitin mpawo chilabelesyegwa munzila zyiingi mumulimo wa chemistry.
Kumuswaangano wa SEC Nephrology wakachitilwa mu May 20, 2025, kabunga kakalanga-langa makanze aakuzumizya kupanga akusambala kwa 100 mmol/L calcium chloride dihydrate infusion solution kuti ibelesyegwe mu "busilisi bwakucinca calcium mukuzumanana kwakucinca nswi (CRRT), kuzumanana kwabulwazi butabeleki kabotu (DDDS) kusanduka kwa plasma (TPE) antoomwe a citrate anticoagulation. Musamu ooyu utondezyegwa kubapati abana” mpawo wakapa kaambo kakugwisigwa kuzwa kumasunko aachiimo cha III a IV.
Nikwakainda mubandi uuzwide, kkomiti yakalumbaizya kuti twaambo twakuzumizya, antoomwe a data ya phase III yakusunkwa kwakusilikwa alimwi a data yakulanga-langa kuzwa kuzisi zyakazumizya musamu ooyu, zyeelede kupegwa ku komiti kuti zilangwe-langwe.
Bala alimwi: Kabunga ka CDSCO kakazumizya kulemba kwa Sanofi's Myozyme, kakakumbila kulanga-langa kwamilawu
Dr. Divya Kolin wakamanizya chikolo cha PharmD ujisi luzibo lunji lwabusilisi amuchibbadela alimwi aluzibo lubotu lwakupima akusilisya. Wakabeleka alubo kali musilisi wa misamu ya kkansa mu dipatimenti ya kkansa ku Mysore Medical College and Research Institute. Lino ulikuchitila mulimo wakwe wakuvwuntauzya zyabusilisi akulanganya data yabusilisi. walikubeleka a Medical Dialogue kuzwa mu January 2022.
       Dr Kamal Kant Kohli, MBBS, MD, CP, is a thoracic specialist with over 30 years of experience and specializes in clinical writing. He joins Medical Dialogues as the Editor-in-Chief of Medical News. Apart from writing articles, as the Editor, he is responsible for proofreading and reviewing all medical content published in Medical Dialogues, including content from journals, research papers, medical conferences, guidelines, etc. Email: drkohli@medicaldialogues.in Contact: 011-43720751
Buvwuntauzi bwa ABYSS bwakajana kuti kuleka kubelesya ma beta-blockers nikwakamana kuchiswa moyo kwakapa kuti bulowa buyungizigwe, moyo uzungaane, antoomwe azintu zitali kabotu zyamoyo: ...